en · de · es · fr · pt
lab-handbook.peptides7250.com › Blog › Structure And Receptor Pharmacology — Evidence Review

Structure And Receptor Pharmacology — Evidence Review

By Editorial Desk · published 2026-04-08 · last reviewed 2026-05-27 · Blog

A practical reference on GHRH analogue: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.

Reviewed 2026-05-27. Anything still debated is marked as such rather than presented as settled.

Structure And Receptor Pharmacology

CJC-1295 belongs to a class of synthetic peptides modeled on growth hormone releasing hormone, a forty-four amino acid signal produced by the hypothalamus. The compound is built from the first twenty-nine residues of the natural sequence, with four substitutions introduced at positions 2, 8, 15 and 27. These changes were designed to slow enzymatic breakdown while preserving receptor activation. The result is a peptide that is shorter than native GHRH and considerably more resistant to ordinary clearance pathways in circulation.

Two related forms appear under the CJC-1295 name. The simpler analogue, commonly written as modified GRF(1-29), carries the four substitutions but no additional conjugation. The second form attaches a maleimidopropionic acid linker to a lysine residue, a modification frequently called the drug affinity complex. That linker reacts with the free thiol on serum albumin to form a covalent bond. Because albumin has a long residence time in blood, the conjugated peptide stays in circulation far longer than the unconjugated analogue.

Receptor level activity follows the canonical GHRH pathway. The peptide binds the GHRH receptor, a class B G protein coupled receptor on somatotroph cells of the anterior pituitary. Binding raises intracellular cyclic AMP, which promotes calcium entry and the release of growth hormone into the bloodstream. Because the molecule acts at the same receptor as the endogenous hormone, its effect is superimposed on the natural pulsatile rhythm rather than replacing it. Whether sustained receptor occupation leads to desensitization is not fully settled.

Identity and Naming History

CJC-1295 is the name used for a synthetic peptide modeled on growth hormone-releasing hormone, the hypothalamic signal that prompts the pituitary to release growth hormone. The compound was described by a Canadian drug discovery company in the mid-2000s as a long-acting research tool. Two closely related molecules share the name in practice: one carries a drug affinity complex, or DAC, group, and one does not. The distinction matters because the two behave differently in circulation.

The peptide backbone corresponds to GRF(1-29), the first 29 residues of native growth hormone-releasing hormone, which retains most of the receptor-activating activity of the full-length molecule. Four substitutions distinguish the analog from the natural sequence: D-alanine at position 2, glutamine at position 8, alanine at position 15, and leucine at position 27. These changes slow cleavage by dipeptidyl peptidase IV, the enzyme that degrades native hormone in plasma within minutes. The outcome is improved enzymatic stability combined with a still brief residence time when no additional modification is present.

Naming in this area is inconsistent, and readers should treat product labels with care. In much of the literature and in vendor catalogs, the unqualified term refers to the albumin-binding version, while the version lacking the DAC group appears as modified GRF(1-29), mod GRF(1-29), or the same name with a without-DAC qualifier. Because one abbreviation has been applied to both materials, the only reliable way to identify a sample is to check the stated sequence and the presence of the linker.

Cjc-1295 at a glance

PropertyValueNotes
Peptide classSynthetic GHRH analogueBuilt on a 29 residue sequence
Primary targetGHRH receptor (GHRHR)Class B G protein coupled receptor
Unconjugated half lifeMinutesLimited by protease degradation
Key modificationFour residue substitutionsPositions 2, 8, 15 and 27
Common synonymModified GRF(1-29)Usually denotes the form without DAC

Receptor Action and Clearance

Once in circulation, the peptide binds the growth hormone-releasing hormone receptor displayed on pituitary somatotroph cells. Receptor activation couples to Gs proteins, elevates intracellular cyclic AMP, and drives protein kinase A signaling inside the cell. That cascade increases discharge of growth hormone into the bloodstream. The analog therefore operates through a receptor pathway that already exists for the body's own releasing hormone, rather than through an engineered artificial target.

Clearance profiles diverge sharply between the two versions. The albumin-binding molecule stays in plasma for several days, whereas the unmodified analog is largely gone within about half an hour in reported work. Cleavage by dipeptidyl peptidase IV is a major contributor to the short life of the unmodified sequence. These gaps mean the two versions cannot be substituted for each other in study design or in reading results side by side.

Related pages on this site

Persistence, Stability and Measurement

The two variants differ dramatically in how long they persist in circulation. The form lacking the albumin-binding group has a plasma half-life measured in tens of minutes, comparable to the natural hormone fragment. The version carrying the drug affinity complex binds albumin and shows a half-life of roughly six to eight days in human studies. That figure comes from small trials that tracked hormone levels over extended periods. The physiological consequences of sustained versus pulsatile stimulation are still debated and the literature does not settle the point.

Lyophilized peptide powder is comparatively stable when kept dry, cold, and protected from light. Once dissolved, the molecule is vulnerable to deamidation, oxidation, and aggregation, with the rate depending on pH, buffer composition, and temperature. Alkaline conditions and repeated freeze-thaw cycles accelerate loss of the intact peptide. The methionine present in the native sequence is a known oxidation site, which is one reason it was replaced in the modified fragment. Suppliers typically recommend cold storage of solutions and use within a short window.

Notes from published material

== Bone versus cartilage == The primitive skeleton is cartilage, a solid avascular (without blood vessels) tissue in which individual cartilage-matrix secreting cells, or chondrocytes, occur. Chondrocytes do not have intercellular connections and are not coordinated in units. Cartilage is composed of a network of collagen type II held in tension by water-absorbing proteins, hydrophilic proteoglycans. This is the adult skeleton in cartilaginous fishes such as sharks. It develops as the initial skeleton in more advanced classes of animals. In air-breathing vertebrates, cartilage is replaced by cellular bone. A transitional tissue is mineralized cartilage. Cartilage mineralizes by massive expression of phosphate-producing enzymes, which cause high local concentrations of calcium and phosphate that precipitate. This mineralized cartilage is not dense or strong. In the air breathing vertebrates it is used as a scaffold for formation of cellular bone made by osteoblasts, and then it is removed by osteoclasts, which specialize in degrading mineralized tissue. Osteoblasts produce an advanced type of bone matrix consisting of dense, irregular crystals of hydroxyapatite, packed around the collagen ropes. This is a strong composite material that allows the skeleton to be shaped mainly as hollow tubes. Reducing the long bones to tubes reduces weight while maintaining strength.

=== Interactions with IgG and serum albumin === In addition to binding to IgG, FCGRT has been shown to interact with human serum albumin. FcRn-mediated transcytosis of IgG across epithelial cells is possible because FcRn binds IgG at acidic pH (<6.5) but not at neutral or higher pH. The binding site for FcRn on IgG has been mapped using functional and structural studies, and involves in the interaction of relatively well conserved histidine residues on IgG with acidic residues on FcRn.

After receiving a missile targeting device disguised as a gem from Agent Abrella, she travels to Earth in the Kaijuki Devil Capture 5 (デビルキャプチャー5, Debiru Kyapuchā Faibu), which is destroyed by Deka Bike Robo while she is captured by S.P.D.'s Earth unit. She escapes to rekindle a former relationship, but is confronted by the Dekarangers and learns of Abrella's true intentions. Once the Dekarangers stop the missile and jettison Faraway to safety, she is pardoned. Faraway is portrayed by Aja (あじゃ). Tokasaian Princess Io Yonmerluicchi (トカーサ星人イオ・ヨンマールイッチ, Tokāsa Seijin Io Yonmāruitchi): A princess from Planet Tokasa who resembles Umeko. Io Yonmerluicchi is portrayed by Mika Kikuchi, who also portrays Umeko. Chanbenarian Gin (チャンベーナ星人ギン, Chanbēna Seijin Gin): A feline alien child from Planet Chanbenar who tries to steal medicine from Hakutaku, for his sick mother, after he was unable to buy it with a pearl he found, but is stopped and befriended by Sen-chan. After surviving an attempt on his life by an Alienizer named Gineka, who used the pearl in his Kaijuki game, Gin's mother receives medicine from Hakutaku at Sen-chan's request. Gin is voiced by Yōko Teppōzuka (鉄炮塚 葉子, Teppōzuka Yōko). Teranian Chou San (テラン星人チョウ・サン, Teran Seijin Chō San): A retired veteran detective from Planet Teran who seeks revenge on an Alienizer named Raja Namunan for killing his daughter 13 years prior, but was never able to prove it. In the present, Jasmine shows him the errors of his ways while confirming his theory. Chou San is voiced by Seizō Katō (加藤 精三, Katō Seizō).

Sources: en.wikipedia.org

Background from the literature

Jasleen Kaur is named as the winner of the 2024 Turner Prize. 4 December Cheshire Constabulary confirms they have interviewed Lucy Letby under caution in prison about further baby deaths. The former prime minister, Boris Johnson, accuses Starmer of misleading the House of Commons and says he should correct the record immediately. This follows an exchange in the House during PMQs when Starmer, answering a question from the leader of the opposition, Kemi Badenoch, said that "two of her predecessors had convictions for breaking the Covid rules". Although the former Conservative prime ministers, Johnson and Rishi Sunak had received fixed penalty notices for breaking COVID-19 regulations, neither had any criminal convictions. 5 December – The Princess of Wales hosts her annual Christmas carol service at Westminster Abbey. 6 December Data published by the Halifax Bank indicates house prices rose by 1.3% in November 2024, marking the fifth consecutive month of growth, with the average house price now estimated at £298,083. Around three million people in Wales and South West England are sent emergency alerts as Storm Darragh approaches the UK. The owners of The Observer confirm the newspaper has been sold to Tortoise Media. The Royal Mint unveils a collector's edition £5 coin featuring Sir Paul McCartney. The UK government announces a £500m contract to build 14 "state-of-the-art" trains at Hitachi's Newton Aycliffe factory, securing the facility's future.

=== Selenocysteine and selenomethionine === Selenocysteine, called the twenty-first amino acid, is essential for ribosome-directed protein synthesis in some organisms. More than 25 selenium-containing proteins (selenoproteins) are now known. Most selenium-dependent enzymes contain selenocysteine, which is related to cysteine analog but with selenium replacing sulfur. This amino acid is encoded in a special manner by DNA. Selenosulfides are also proposed as biochemical intermediates. Selenomethionine is a selenide-containing amino acid that also occurs naturally, but is generated by post-transcriptional modification.

The following retirements from the House of Lords are announced by Lord McFall of Alcluith by virtue of non-attendance: John Prescott, Conrad Black and Jeffrey Archer. 11 July – The SNP confirms it will have to make the majority of its Westminster staff redundant after Parliament reduces its "Short Money" – the annual amount paid to opposition parties – by £1m. Peter Martin becomes the DUP MLA for North Down after the previous incumbent, Alex Easton was elected to Westminster. A week after his election to Parliament, GB News announces that Nigel Farage is returning to his show on the channel, presenting on Tuesdays, Wednesdays and Thursdays from 16 July. 12 July – Justice Secretary Shabana Mahmood confirms that thousands of prisoners in England and Wales will be released early from their sentences at the beginning of September, warning of the "total collapse" of the prison system and a "total breakdown of law and order" without steps being taken to ease prison overcrowding. 14 July – Leading UK political figures, including Sir Keir Starmer and Nigel Farage, condemn the previous day's attempted assassination of Donald Trump in the United States. Foreign Secretary David Lammy makes his first visit to Israel and the Palestinian territory to hold talks with leaders. Lord Walney, the UK government's adviser on political violence, writes to the Home Secretary urging an inquiry into potential intimidation of candidates at the general election by groups in different constituencies.

Sources: en.wikipedia.org

Frequently asked questions

Is CJC-1295 the same as modified GRF(1-29)?

The names are often used interchangeably in casual writing, but they are not strictly identical. Modified GRF(1-29) refers to the unconjugated analogue carrying only the four substitutions. The version sold as CJC-1295 with DAC includes the albumin binding linker and clears much more slowly.

What does the acronym DAC refer to?

DAC stands for drug affinity complex, a term describing the maleimidopropionic acid linker. This group forms a covalent bond with the cysteine residue on serum albumin after administration. The resulting adduct is what extends the circulating half life from minutes to days.

Does this peptide occur naturally in the body?

No. It is entirely synthetic and does not correspond to any known endogenous peptide. The design starts from human growth hormone releasing hormone and introduces deliberate substitutions. Any biological effect comes from mimicking the natural hormone at its receptor.

Is this compound a naturally occurring hormone?

No. It is a laboratory-made analog of growth hormone-releasing hormone. The natural hormone is a 44-residue peptide, while the analog is built on a shorter 29-residue fragment.

Network